Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 369

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Open access
Loeuillard, Emilien, Yang, Jingchun, Buckarma, EeeLN, Wang, Juan, Liu, Yuanhang, Conboy, Caitlin, Pavelko, Kevin D., Li, Ying, O’Brien, Daniel, Wang, Chen, Graham, Rondell P., Smoot, Rory L., Dong, Haidong, Ilyas, Sumera·2020·Journal of Clinical Investigation

Abstract

Figure 1.TAMs are the predominant source of PD-L1 in CCA.(A) Representative images (left and middle panels) of PD-L1 (brown staining, black arrowhead) plus CD68 (red staining, red arrowhead) coimmunostaining (n = 33) and PD-L1 (brown staining) plus CK-19 (red staining) coimmunostaining (n = 18) in human resected CCA specimens.Percentage of patients with positive PD-L1/CD68 costaining and PD-L1/CK19 costaining, respectively (right panel).Scale bars: 40 μm.(B) Histograms show expression of PD-L1 + macrophages in human CCA tumors.(C-F) Flow cytometry analysis of normal WT mouse livers (from WT mice without tumors) as well as adjacent livers and tumors of mice 28 days after orthotopic implantation of 1 × 10 6 SB (murine CCA) cells.(C) Percentage of PD-L1 + macrophages (Mφ) of total macrophages (CD45 + CD11b + F4/80 + ) in WT mouse normal liver, tumor-adjacent liver, or tumor.Fluorescence Minus One (FMO) controls were used for each independent experiment to establish gates (See Supplemental Figure 1A for gating strategy) (n ≥ 8).Representative histograms show expression of PD-L1 + macrophages.(D) Percentage of CD206 + TAMs (left panel) and PD-L1 + CD206 + TAMs (middle panel) of F4/80 int macrophages (CD45 + CD11b + F4/80 int ) in WT mouse liver, tumor-adjacent liver, or tumor.Representative contour plots (right panel) show CD206 and PD-L1 expression of F4/80 int macrophages (n ≥ 7).(E) Percentage of PD-L1 + CD206 -macrophages or PD-L1 + CD206 + macrophages (CD11b + F4/80 + ) of CD45 + cells from SB tumors (n = 28).(F) Percentage of PD-L1 expression in myeloid cells from SB tumors.Macrophages, CD45 + PD-L1 + CD11b + F4/80 + ; MDSCs, CD45 + PD-L1 + CD11c -CD11b + F4/80 -GR-1 + ; DCs, CD45 + PD-L1 + CD11c hi ; (n = 11).Data are represented as mean ± SD.Unpaired Student's t test (E) and 1-way ANOVA with Bonferroni's post hoc test (C, D, and F) were used.*P < 0.05; **P < 0.01; ***P < 0.001.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci137110

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 369

Metadata

Authors
Loeuillard, E., Yang, J., Buckarma, E., Wang, J., Liu, Y., Conboy, C., Pavelko, K. D., Li, Y., O’Brien, D., Wang, C., Graham, R. P., Smoot, R. L., Dong, H., & Ilyas, S.
Venue
Journal of Clinical Investigation
Published
2020-09-14
Volume
130
Issue
10
Pages
5380-5396
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3043690500
Cited by
369
References
58
FWCI
13.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. https://app.cochat.ai/papers/10.1172/jci137110
The paper
Loeuillard, E., Yang, J., Buckarma, E., Wang, J., Liu, Y., Conboy, C., Pavelko, K. D., Li, Y., O’Brien, D., Wang, C., Graham, R. P., Smoot, R. L., Dong, H., & Ilyas, S. (2020). Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci137110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.